ELElizaveta Lanskaya

Elizaveta Lanskaya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elizaveta Lanskaya has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Management of Abnormal Uterine Bleeding in a Patient “Bridged” with LVAD

    by Maria Simonenko, Eduard Komlichenko, Nadejda Kohreidze, Elizaveta Lanskaya, Marina Ismail, Tatiana Pervunina, Petr Fedotov

    Background: Mechanical circulatory support significantly improved survival in end-stage heart failure patients. However, this treatment associated with a wide range of complications, including infections, stroke and bleeding. Abnormal uterine bleeding (AUB) is often underreported gynecological disorder in female patients following left ventricular assist device (LVAD) implantation. Case Presentation: A 15-year-old female patient with dilated cardiomyopathy and chronic heart failure with reduced ejection fraction underwent implantation of “Heart Mate 3” as a “bridge” to transplant. After LVAD implantation she had recurrent nosebleeds and AUB complicated with moderate anemia. She frequently admitted to the hospital and then managed with antifibrinolytic medication (Tranexamic acid: 500 mg was administered once a day for 3 days) and blood transfusions. By heart team it was decided to reduce antithrombotic therapy: antiplatelets were discontinued and her INR level was maintained 1.4-1.8. For 2 years prior to HTx LVAD function kept fine on minimized antithrombotic therapy without thromboembolic complications. It was made a multidisciplinary team decision to avoid combined oral contraceptives due to the high risk of thromboembolic complications outweighing the benefits. Twice she underwent urgent laparoscopic surgeries but after all her fertile function remained preserved. Conclusions: LVAD patients should be managed with a multidisciplinary heart team. In case of recurrent bleeding and low-risk of thromboembolic complications reduction of antithrombotic therapy should be considered. A personalized approach is essential to determine whether conservative or surgical management is superior, as it balances evidence-based medicine with individual patient needs, reducing the risks of futile or overly aggressive care. Taking into account the reproductive function, an organ-preserving operation was performed for the subsequent preservation of fertile function. Surgical interventions for gynecological disorders can be safely performed in patients “bridged” with LVAD.

  • Open Access

    DIAGNOSTIC CAPABILITIES OF [18F]FDG PET/CT IN CASES OF ENDOMETRIAL CANCER: COMPARISON WITH THE RESULTS OF MORPHOLOGICAL EXAMINATION

    by E. E. Komlichenko, E. V. Lanskaya, E. L. Dikareva, E. V. Komlichenko, E. G. Koshevaya, L. B. Mitrofanova, G. A. Raskin, E. A. Ulrikh, D. V. Ryzhkova

    Background: endometrial cancer is a common oncological disease of the female reproductive system. Treatment is based on a comprehensive analysis of FIGO staging, degree of differentiation, invasion, and molecular genetic profile of the tumor. Objective: comparative analysis of the metabolic characteristics of the primary tumor based on PET/CT results with [18F]FDG and key prognostic factors of endometrial cancer according to morphological and immunohistochemical studies. Design and methods: A retrospective analysis of 34 patients with morphologically verified endometrial cancer who underwent PET/CT prior to surgical treatment with [18F]FDG. The relationship between the quantitative metabolic characteristics of the primary tumor: the standardized accumulation level (SUVmax), the metabolic volume of the tumor (MTV) and the total glycolytic index (TLG) of the primary tumor with the histological type, degree of differentiation (Grade), the depth of invasion into the myometrium, the presence of lymphovascular invasion and damage to the lymph nodes was investigated. Results: A statistically significant strong positive correlation was found between SUVmax and the degree of neoplasm anaplasia (p=0.68, p0.001). The SUVmax values significantly differed between the Grade groups: Grade 1 – 7.25, Grade 2 – 7.22, and Grade 3 – 12.80 (p0.001). Non-endometrioid histological types and the presence of LVI were also associated with higher values of SUVmax, MTV, and TLG. A moderate positive correlation of SUVmax with the depth of tumor invasion into the myometrium was found (p=0.58, p=0.001). Conclusion: quantitative metabolic characteristics of the primary tumor obtained by PET/CT scans with [18F]FDG can be used for predictive risk stratification as part of a personalized approach to endometrial cancer treatment, as they are closely related to the main histopathological prognostic factors of biological tumor aggressiveness.